Marc T. Goodman (United States of America)
Cedars Sinai Medicine
Presenter of 1 Presentation
UPDATE ON TRENDS IN OROPHARYNX CANCER INCIDENCE FROM CANCER INCIDENCE IN FIVE CONTINENTS (ID 366)
Session Time
14:15 - 15:15
Session Type
Public Health Oral Session
Lecture Time
14:15 - 14:27
[{"name":"UPDATE ON TRENDS IN OROPHARYNX CANCER INCIDENCE FROM CANCER INCIDENCE IN FIVE CONTINENTS \u003Csmall\u003E(ID 366)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":366,"presentation":"UPDATE ON TRENDS IN OROPHARYNX CANCER INCIDENCE FROM CANCER INCIDENCE IN FIVE CONTINENTS \u003Csmall\u003E(ID 366)\u003C\/small\u003E","session":"Oral Session 17: HEAD & NECK CANCERS. Epidemiology, natural history and prevention","presenter":"Marc T. Goodman (United States of America)","photo":""},"playlist":[{"name":"UPDATE ON TRENDS IN OROPHARYNX CANCER INCIDENCE FROM CANCER INCIDENCE IN FIVE CONTINENTS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/71\/NEW_Marc Goodman IPVC20 366 UPDATE ON TRENDS IN OROPHARYNX CANCER INCIDENCE FROM CANCER INCIDENCE IN FIVE CONTINENTS.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/71\/NEW_Marc Goodman IPVC20 366 UPDATE ON TRENDS IN OROPHARYNX CANCER INCIDENCE FROM CANCER INCIDENCE IN FIVE CONTINENTS.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/71\/C526A614.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/71\/NEW_Marc Goodman IPVC20 366 UPDATE ON TRENDS IN OROPHARYNX CANCER INCIDENCE FROM CANCER INCIDENCE IN FIVE CONTINENTS.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22UU07j"}
[session]
[presentation]
[presenter]
Moderator of 1 Session
Session Type
Clinical Science Oral Session
Session Time
08:30 - 09:20
[{"name":"YIELD OF LOOP ELECTROSURGICAL EXCISION PROCEDURE (LOOP) AMONG PATIENTS WITH AND WITHOUT KNOWN HIGH GRADE CERVICAL DYSPLASIA \u003Csmall\u003E(ID 983)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":983,"presentation":"YIELD OF LOOP ELECTROSURGICAL EXCISION PROCEDURE (LOOP) AMONG PATIENTS WITH AND WITHOUT KNOWN HIGH GRADE CERVICAL DYSPLASIA \u003Csmall\u003E(ID 983)\u003C\/small\u003E","session":"Oral Session 8: Screening and Management Cervix Lesions","presenter":"Shuk On Annie A. Leung (United States of America)","photo":""},"playlist":[{"name":"YIELD OF LOOP ELECTROSURGICAL EXCISION PROCEDURE (LOOP) AMONG PATIENTS WITH AND WITHOUT KNOWN HIGH G","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/Shuk On Annie Leung_983_1010_YIELD OF LOOP ELECTROSURGICAL.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/79\/Shuk On Annie Leung_983_1010_YIELD OF LOOP ELECTROSURGICAL.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/C0D91A2.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/Shuk On Annie Leung_983_1010_YIELD OF LOOP ELECTROSURGICAL.vtt"}]},{"name":"INTERNATIONAL QUALITY ASSURANCE OF HPV DNA GENOTYPING SERVICES: THE 2019 GLOBAL HPV DNA PROFICIENCY STUDY \u003Csmall\u003E(ID 771)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":771,"presentation":"INTERNATIONAL QUALITY ASSURANCE OF HPV DNA GENOTYPING SERVICES: THE 2019 GLOBAL HPV DNA PROFICIENCY STUDY \u003Csmall\u003E(ID 771)\u003C\/small\u003E","session":"Oral Session 8: Screening and Management Cervix Lesions","presenter":"Joakim Dillner (Sweden)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/77.jpg"},"playlist":[{"name":"INTERNATIONAL QUALITY ASSURANCE OF HPV DNA GENOTYPING SERVICES: THE 2019 GLOBAL HPV DNA PROFICIENCY ","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/part 1-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/79\/part 1-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/2033BB09.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/part 1-0.vtt"}]},{"name":"FIRST-VOID URINE AS AN ALTERNATIVE TO PHYSICIAN-TAKEN SAMPLES FOR HPV SCREENING \u003Csmall\u003E(ID 1269)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1269,"presentation":"FIRST-VOID URINE AS AN ALTERNATIVE TO PHYSICIAN-TAKEN SAMPLES FOR HPV SCREENING \u003Csmall\u003E(ID 1269)\u003C\/small\u003E","session":"Oral Session 8: Screening and Management Cervix Lesions","presenter":"Michelle Laeremans (Belgium)","photo":""},"playlist":[{"name":"FIRST-VOID URINE AS AN ALTERNATIVE TO PHYSICIAN-TAKEN SAMPLES FOR HPV SCREENING","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/Michelle Laeremans - IPVC20 1269 FIRST-VOID URINE AS AN ALTERNATIVE TO PHYSICIAN-TAKEN SAMPLES FOR HPV SCREENING 001.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/79\/Michelle Laeremans - IPVC20 1269 FIRST-VOID URINE AS AN ALTERNATIVE TO PHYSICIAN-TAKEN SAMPLES FOR HPV SCREENING 001.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/56C0523B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/Michelle Laeremans - IPVC20 1269 FIRST-VOID URINE AS AN ALTERNATIVE TO PHYSICIAN-TAKEN SAMPLES FOR HPV SCREENING 001.vtt"}]},{"name":"CLINICAL EVALUATION OF ALINITY M HR HPV ASSAY IN POPULATION-BASED CERVICAL CANCER SCREENING SETTING \u003Csmall\u003E(ID 940)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":940,"presentation":"CLINICAL EVALUATION OF ALINITY M HR HPV ASSAY IN POPULATION-BASED CERVICAL CANCER SCREENING SETTING \u003Csmall\u003E(ID 940)\u003C\/small\u003E","session":"Oral Session 8: Screening and Management Cervix Lesions","presenter":"Anja Ostrbenk Valencak (Slovenia)","photo":""},"playlist":[{"name":"CLINICAL EVALUATION OF ALINITY M HR HPV ASSAY IN POPULATION-BASED CERVICAL CANCER SCREENING SETTING","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/Anja Ostrbenk Valencak IPVC20 940.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/79\/Anja Ostrbenk Valencak IPVC20 940.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/3816ABF5.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/79\/Anja Ostrbenk Valencak IPVC20 940.vtt"}]}]
{"type":2,"code":"7E32UU02n"}
[session]
[presentation]
[presenter]
